SWORD Health closes on $85 million Series C for virtual MSK care
SWORD Health, a virtual musculoskeletal care platform founded in 2015, announced today that it has raised an $85 million Series C funding round led by General Catalyst.
You may find something interesting here, once in a while.
SWORD Health, a virtual musculoskeletal care platform founded in 2015, announced today that it has raised an $85 million Series C funding round led by General Catalyst.
Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding
Moveshelf secured a seed investment to accelerate the digital transformation of diagnosis and care for movement disorders. Utrecht Health Seed Fund (UHSF) and Locapes Investment Fund contributed to this round.
SWORD Health Raises $25 Million in Series B to Accelerate Growth of its Best-in-Class Virtual Musculoskeletal Care Solution
Nederlandse medtech-startup Spektrax ontwikkelt met hulp van het Amsterdam UMC een test waarmee binnen een paar minuten kan worden vastgesteld of iemand besmet is met het coronavirus.
European Investment Bank and Atriva Therapeutics sign financing agreement of €24 million for the research, development and clinical testing of the company’s lead product candidate against influenza and COVID-19.